Sökning: onr:"swepub:oai:DiVA.org:liu-155844" >
Higher levels of SD...
Higher levels of SDMA and not ADMA are associated with poorer survival of trial patients with systemic ANCA-associated vasculitis
-
- Erdbrügger, Uta (författare)
- Division of Nephrology, Department of Medicine, University of Virginia Health System, Virginia, USA
-
- Kielstein, Jan T (författare)
- Department of Hypertension and Nephrology, Medical Clinic V, Klinikum Braunschweig, Braunschweig, Germany
-
- Westman, Kerstin (författare)
- Department of Nephrology, Lund University, Lund, Sweden
-
visa fler...
-
- Ma, Jennie Z (författare)
- Department of Biostatistics, University of Virginia Health System, Virginia, USA
-
- Xin, Wenjun (författare)
- Department of Biostatistics, University of Virginia Health System, Virginia, USA
-
- Bode-Böger, Stephanie M (författare)
- Otto-von-Guericke University, Institute of Clinical Pharmacology, Magdeburg, Germany
-
- Segelmark, Mårten, 1957- (författare)
- Linköpings universitet,Avdelningen för läkemedelsforskning,Medicinska fakulteten,Region Östergötland, Njurmedicinska kliniken US
-
- Rasmussen, Niels (författare)
- Department of Biochemistry and Immunology, Statens Seruminstitut, Copenhagen, Denmark
-
- De Groot, Kirsten (författare)
- Department of Nephrology and Rheumatology, Medical Clinic III, Sana Klinikum, Offenbach, Germany
-
visa färre...
-
(creator_code:org_t)
- AVES, 2018
- 2018
- Engelska.
-
Ingår i: European journal of rheumatology. - : AVES. - 2147-9720 .- 2148-4279. ; 5:3, s. 153-159
- Relaterad länk:
-
https://doi.org/10.5...
-
visa fler...
-
https://urn.kb.se/re...
-
https://doi.org/10.5...
-
visa färre...
Abstract
Ämnesord
Stäng
- Endothelial dysfunction, increased cardiovascular events (CVE), and accelerated atherosclerosis have been described in patients with small vessel vasculitis and collagen vascular disease. Identifying predictors of cardiovascular risk will help to optimize short- and long-term care of patients with vasculitis. The present study investigates the predictive role of the endogenous nitric oxide synthase (NOS) inhibitor asymmetric dimethylarginine (ADMA) and its stereoisomer symmetric dimethylarginine (SDMA) for cardiovascular risk, all-cause mortality, and renal function in patients with anti-neutrophil-cytoplasmic antibodies-associated small vessel vasculitis (AASV) subjected to standardized treatment regimens in four European Vasculitis Study Group trials representing all stages of renal disease.
Ämnesord
- MEDICIN OCH HÄLSOVETENSKAP -- Klinisk medicin -- Kardiologi (hsv//swe)
- MEDICAL AND HEALTH SCIENCES -- Clinical Medicine -- Cardiac and Cardiovascular Systems (hsv//eng)
Publikations- och innehållstyp
- ref (ämneskategori)
- art (ämneskategori)
Hitta via bibliotek
Till lärosätets databas